Tweet What do we believe the latest from ECTRIMS 2025 or the great and the good. But as you can see there is confusion as you have papers from ectrims telling us that most of the smouldering lesions can be accounted for by inflammatory activity…
Paramagnetic rim lesions (PRLs), which represent areas of damage in the brain and spinal cord with chronic active inflammation, are highly indicative of multiple sclerosis (MS) in people being evaluated […] The post Paramagnetic rim lesions could help in diagnosing MS early: Study appeared first…
I recently got my yearly influenza vaccine, which protects against the flu. According to the U.S. Centers for Disease Control and Prevention (CDC), “In an average year, thousands of people […] The post Getting vaccinated helps me protect myself and others with MS appeared first…
Beyond the Usual: An Inside Look at Weird MS Symptoms While many are familiar with common multiple sclerosis (MS) symptoms like fatigue, vision problems, and muscle weakness, the reality for those living with the condition often involves a bizarre and … Continue reading → Source:…
Tweet Bexarotene came from studying remylination in cultures and experiments from beasties and this lead to a a trial. However many of the remylination studies find important molecules that have multiple functions throughout the body and so it should come as no surprise that when…
Tweet The diagnositic criteria for MS was updated in 2024 and these criteria were leaked in the Middle East in late 2022 and announced on the blog in 2023. This has been examined in the middle East and the 2024 criteria mean that more people…
Tweet Early High Efficacy treatment verses escalation from a lower efficacy agents was one of the James Lind Alliance top 10 prioritises from 2013 adopted by the MS Society Does early treatment with aggressive disease modifying drugs improve the prognosis for people with MS? The…
By Stacie Prada Life is full of distractions, disruptions, deadlines, and despair. Yet we go on. Sometimes we’re strong and excited, and other times we struggle. The measure of success isn’t an imaginary idea of being perfect. Whether we lead, … Continue reading → Source:…
A generic formulation of Zeposia (ozanimod), which won tentative approval for treating multiple sclerosis (MS) from the U.S. Food and Drug Administration (FDA), will be manufactured and supplied by Synthon, based […] The post New generic version of Zeposia could lower cost of MS treatment appeared…
Tweet So we are on our way to the Late Breaking Abstracts as the show stopper for ECTRIMS….Now that we have had our fill of animal models and Sid had choked on his cornflakes we can get down to the serious stuff. So off to…